GAVILAX
- Product NDC
- 17856-0310
- 11-digit product format
- 178560310
- Labeler code
- 17856
- Product ID
- 17856-0310_4c2078a3-fd70-cb56-e063-6394a90a0ff9
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Polyethylene Glycol 3350
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Labeler
- Atlantic Biologicals Corp.
- Application
- ANDA091077
- Marketing category
- ANDA
- Marketing start
- 2009-10-09
- Substance
- POLYETHYLENE GLYCOL 3350
- Active strength
- 17 g/17g
- Pharmacologic classes
- Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GAVILAX
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| POLYETHYLENE GLYCOL 3350 | 17 g/17g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | G2M7P15E5P |
| Rxcui | 876193, 876214 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 17856-0310-2 | GAVILAX | 72 in 1 CASE | POWDER, FOR SOLUTION | 72 | | 1 |
| 17856-0310-2 | GAVILAX | 2 g in 1 POUCH | POWDER, FOR SOLUTION | 2 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 17856-0310-1 | 17856031001 | 50 CUP, UNIT-DOSE in 1 CASE (17856-0310-1) / 2 g in 1 CUP, UNIT-DOSE | | 2026-06-01 | 0 | | Current |
| 17856-0310-2 | 17856031002 | 72 POUCH in 1 CASE (17856-0310-2) / 2 g in 1 POUCH | 72 pouch | 2026-03-03 | No | No | Current |